Tumor Necrosis Factor Alpha and Interleukin-6 Facilitate Corneal Lymphangiogenesis in Response to Herpes Simplex Virus 1 Infection

ABSTRACT Herpes simplex virus 1 (HSV-1) is a common human pathogen of clinical significance due to its association with vision impairment and encephalitis. In a mouse model of ocular neovascularization, we have previously shown that HSV-1 elicits the genesis of lymphatic vessels into the cornea proper through epithelial cell expression of vascular endothelial growth factor A (VEGFA) dependent upon expression of VEGFR2 during acute infection. We hypothesized that other factors may be involved in lymphangiogenesis, with proinflammatory cytokines as the leading candidates. In the absence of infection or inflammation, intrastromal administration of tumor necrosis factor alpha (TNF-α) coupled with VEGFA elicited lymphatic vessel genesis significantly above either factor alone as well as a vehicle control. Consistent with this observation, anti-TNF-α antibody (Ab) blocked HSV-1-mediated corneal lymphangiogenesis within the first 5 days postinfection. However, TNF-α-deficient (TNF-α−/−) mice displayed a level of corneal vessel growth similar to that shown by wild-type (WT) controls. To investigate the likely redundant nature of cytokines, PCR array analysis of HSV-1-infected TNF-α−/− mice was conducted, and it revealed several factors elevated above those found in HSV-1-infected WT mice, including interleukin-1β (IL-1β), platelet-derived growth factor, angiopoietin 2, insulin-like growth factor 2, and IL-6. Subconjunctival administration of neutralizing Ab to IL-6 blocked lymphangiogenesis in TNF-α−/− mice. Whereas the cornea levels of IL-6 were significantly reduced, there was no appreciable change in the level of IL-1β or other proangiogenic factors analyzed. Collectively, the results suggest in addition to VEGFA, TNF-α and IL-6 promote and likely synergize with VEGFA in corneal lymphangiogenesis during acute HSV-1 infection. IMPORTANCE We have identified at least two proinflammatory cytokines expressed locally that are involved in the genesis of lymphatic vessels in the normally avascular cornea in response to HSV-1 infection. This finding provides the basis to target IL-6 and TNF-α as additional proangiogenic factors in the cornea during the development of herpetic stromal keratitis as a means to alleviate further neovascularization and tissue pathology associated with the host immune response to the pathogen.

[1]  K. Maruyama,et al.  Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases , 2013, Progress in Retinal and Eye Research.

[2]  P. Rama,et al.  Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. , 2013, Investigative ophthalmology & visual science.

[3]  R. Hendricks,et al.  Herpes keratitis , 2013, Progress in Retinal and Eye Research.

[4]  W. Min,et al.  Functional analyses of TNFR2 in physiological and pathological retina angiogenesis. , 2013, Investigative ophthalmology & visual science.

[5]  N. Mukaida,et al.  Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization. , 2012, Investigative ophthalmology & visual science.

[6]  W. Halford,et al.  The Herpes Simplex Virus-1 Transactivator Infected Cell Protein-4 Drives VEGF-A Dependent Neovascularization , 2011, PLoS pathogens.

[7]  R. Dana,et al.  Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes , 2011, The Journal of experimental medicine.

[8]  D. Carr,et al.  VEGF-A expression by HSV-1–infected cells drives corneal lymphangiogenesis , 2009, The Journal of experimental medicine.

[9]  寺坂 祐樹 Induction of IL-6 in transcriptional networks in corneal epithelial cells after herpes simplex virus type 1 infection , 2010 .

[10]  D. McDonald,et al.  TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. , 2009, The Journal of clinical investigation.

[11]  K. Alitalo,et al.  Molecular biology and pathology of lymphangiogenesis. , 2008, Annual review of pathology.

[12]  V. Goldberg,et al.  Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. , 2007, Bone.

[13]  N. Van Rooijen,et al.  Tumor Necrosis Factor (TNF) Protects Resistant C57BL/6 Mice against Herpes Simplex Virus-Induced Encephalitis Independently of Signaling via TNF Receptor 1 or 2 , 2006, Journal of Virology.

[14]  J. Martin Collinson,et al.  Corneal avascularity is due to soluble VEGF receptor-1 , 2006, Nature.

[15]  Ashok Kumar,et al.  Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells , 2006, Immunology.

[16]  L. Debusk,et al.  Dual functional roles of Tie-2/angiopoietin in TNF-α-mediated angiogenesis , 2004 .

[17]  K. Hashimoto,et al.  Absence of tumour necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections. , 2004, The Journal of general virology.

[18]  J. Kaczorowski,et al.  Regional Distribution of Antibodies to Herpes Simplex Virus Type 1 (HSV-1) and HSV-2 in Men and Women in Ontario, Canada , 2003, Journal of Clinical Microbiology.

[19]  T. L. Keadle,et al.  IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. , 2000, Investigative ophthalmology & visual science.

[20]  M. Dana,et al.  Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. , 1999, Investigative ophthalmology & visual science.

[21]  C. Foster,et al.  Cytokine mRNA in BALB/c mouse corneas infected with herpes simplex virus , 1999, Eye.

[22]  M. Dana,et al.  TNF-alpha regulates corneal Langerhans cell migration. , 1999, Journal of immunology.

[23]  M. Dana,et al.  TNF-α Regulates Corneal Langerhans Cell Migration , 1999, The Journal of Immunology.

[24]  I. Campbell,et al.  Transgenic expression of interleukin-6 in the central nervous system confers protection against acute herpes simplex virus type-1 infection. , 1999, Journal of neurovirology.

[25]  P. Hodgkin,et al.  Generation of Splenic Follicular Structure and B Cell Movement in Tumor Necrosis Factor–deficient Mice , 1998, The Journal of experimental medicine.

[26]  D. Carr,et al.  Role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent herpes simplex virus type 1. , 1998, Journal of immunology.

[27]  A. Cunningham,et al.  In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-infected keratinocytes contribute to their production? , 1998, The Journal of infectious diseases.

[28]  J. Kriesel,et al.  Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation. , 1997, The Journal of infectious diseases.

[29]  S. Kaufmann,et al.  Application of knockout mice to the experimental analysis of infections with bacteria and protozoa. , 1994, Trends in microbiology.

[30]  H. Staats,et al.  Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy. , 1993, Journal of immunology.

[31]  L. Melton,et al.  Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. , 1989, Archives of ophthalmology.

[32]  W. Risau,et al.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J W DUGGAN,et al.  Herpes simplex virus. , 1961, Transactions of the Canadian Ophthalmological Society.